FDA Inspection 1156155 — Marnel Pharmaceuticals, LLC
The FDA completed an inspection of Marnel Pharmaceuticals, LLC on Nov 3, 2021 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 3, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Scottsdale, AZ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)